EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma

Kristina Mae Bienes, Akira Yokoi, Masami Kitagawa, Hiroaki Kajiyama, Morten Thaysen-Andersen, Rebeca Kawahara

BBA Advances · 2025 · 7 · 100140

DOI: 10.1016/j.bbadva.2025.100140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BBA Advances, 2025. Verfasst von Kristina Mae Bienes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Glyco-core Research (iGCORE), Nagoya University, Emergent/Innovative Engineering Building Room 815, Furo-cho, Chikusa-ku, Nagoya, Aichi…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Research Council, Fusion Oriented REsearch for disruptive Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian carcinoma (HGSOC) is a deadly subtype of ovarian cancer (OC), often diagnosed at late stages due to nonspecific symptoms and lack of effective markers for early detection. Aberrant protein N-linked glycosylation has been reported in HGSOC, holding a potential for improving the diagnosis and prognosis of affected patients. Building on our recent observation documenting that HGSOC-derived extracellular vesicles (EVs) exhibit aberrant protein expression patterns, we here explore the protein N-glycosylation displayed by EVs isolated from HGSOC cell lines and patient ascites relative to those from matching controls to unveil candidate markers for HGSOC. Comparative glycoproteomics of small EVs (sEVs, 200 nm) isolated from HGSOC and non-cancerous cell lines revealed lower overall N-glycosylation of EV proteins and a decreased protein expression of oligosaccharyltransferase (OST) subunits from HGSOC compared to non-cancerous cell lines. Increased α2,6-sialylation was also observed in m/lEVs from HGSOC cell lines and patient ascites by lectin blotting, which correlated with increased gene expression of ST6GAL1 and decreased gene expression of ST3GAL3/4 in HGSOC compared to normal ovary tissues. Our study provides insights into the EV glycoproteome of HGSOC and the underlying changes in the glycosylation machinery in HGSOC tissues, opening new avenues for the discovery of novel markers against HGSOC.

Schlagwörter

Stichwörter der Autor:innen

AscitesBiomarkerExtracellular vesiclesGlycoproteinsGlycoproteomicsHigh grade serous carcinomaN-glycansOvarian cancer

Autor:innen und Institutionen

  • Institute for Glyco-core Research (iGCORE), Nagoya University, Emergent/Innovative Engineering Building Room 815, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan.
  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
  • Nagoya University Institute for Advanced Research, Japan.
  • School of Natural Sciences, Macquarie University, Australia.

Förderung

  • Australian Research Council
  • Fusion Oriented REsearch for disruptive Science and Technology

Zitieren

APA

Bienes, K. M., Yokoi, A., Kitagawa, M., Kajiyama, H., Thaysen-Andersen, M., & Kawahara, R. (2025). Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma. BBA Advances, 7, 100140. https://doi.org/10.1016/j.bbadva.2025.100140

Vancouver

Bienes KM, Yokoi A, Kitagawa M, Kajiyama H, Thaysen-Andersen M, Kawahara R. Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma. BBA Advances. 2025;7:100140. doi:10.1016/j.bbadva.2025.100140

BibTeX
@article{Bienes2025,
  author = {Bienes, Kristina Mae and Yokoi, Akira and Kitagawa, Masami and Kajiyama, Hiroaki and Thaysen-Andersen, Morten and Kawahara, Rebeca},
  title = {Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma},
  journal = {BBA Advances},
  year = {2025},
  volume = {7},
  pages = {100140},
  doi = {10.1016/j.bbadva.2025.100140}
}
Kostenlos starten →